Philips Medical Systems Recalls Imaging Systems Due to Malfunction Risk
Philips Medical Systems recalled 2,114 Allura Xper FD20 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, risking loss of motorized functionality. This recall affects 791 units in the U.S. and 1,323 globally.
Hazard Information
Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
Product Details
The recalled product codes include 722012, 722028, and 722006. These systems were distributed worldwide, including the U.S. and countries such as Canada, Germany, and Australia. No price information is available.
The Hazard
The imaging systems may not perform as intended if internal components, such as the CMOS battery or power supply unit, deteriorate. This can lead to loss of motorized movements, although manual movements and imaging capabilities will remain functional.
Reported Incidents
No specific injuries or incidents have been reported connected to this recall. The risk level is classified as high due to potential operational failures.
What to Do
Healthcare providers and patients should stop using the affected devices immediately. Contact Philips Medical Systems for further instructions on the recall process.
Contact Information
For more information, contact Philips Medical Systems Nederland B.V. or visit the FDA recall notice at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2626-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.